U.S. Food and Drug Administration

U.S. Food and Drug Administration Articles

Earnings season has mostly wound down.  We have many key business events and key economic events scheduled for next week.  In asset sales and merger land, we will be paying close attention to...
This week’s Unusual Suspects are not just about earnings season, despite the deluge and onslaught we are about to see.  We have a watch for events this week in shares of Acorda Therapeutics, Inc....
Cell Therapeutics, Inc. (NASDAQ: CTIC) has announced what may be a large breakthrough in the fight against cancer.  This is a combined test rather than as a standalone treatment, but the result may...
We have almost a whole new slate of stocks in this week’s round of “The Unusual Suspects” for key stocks traders need to keep an eye on for the week ahead.  Activision Blizzard Inc. (NASDAQ:...
Diabetes is becoming an epidemic in the U.S. and the Western World.  The ties to obesity are often direct, so the potential treatments are often directly tied as well.  We did a recent dig down for...
Here are some of the top stories affecting key drug and biotech stocks that have links through to more in-depth coverage and analysis today at the website BioHealthInvestor.com: Rigel Pharmaceuticals...
These are some of the top stories affecting key drug and biotech stocks that are covered with more in-depth details and analysis this morning at BioHealthInvestor.com: Amgen Inc’s (Nasdaq:...
Here are some of the top stories affecting key drug and biotech stocks that are covered in-depth today at BioHealthInvestor.com: Cigna corp. (NYSE: CI), Aetna Inc. (NYSE: AET), and other managed care...
There is still some conversation about the federal government restricting short-selling activity in certain stocks. The counterargument to these restrictions is that short selling plays an important...
Reuters:   California declared a financial emergency. Reuters:   An SEC attorney raised concern about a Madoff report in 2004. Reuters:   Auto parts supplier Lear filed for bankruptcy....
Reuters:   California raced to approve a state budget its cutting deficit. Reuters:   Ten more people may face charges in Madoff case. Reuters:   Gannett (GCI) is laying off 1,000 more people....
Novartis AG (NYSE: NVS) shares are at session highs and well of the lows of the day in the early afternoon Thursday after Japan okayed one of the company’s human growth hormones, the first approval...
Palomar Medical Technologies Inc. (NASDAQ: PMTI) is seeing shares surge to new heights not seen in 18-months.  The company is the first to receive FDA approval for over-the-counter clearance for a...
Dendreon Corporation (NASDAQ: DNDN) was started with a Buy rating and a $36.00 target at Deutsche Bank.  The call’s positive expectations are mixed near-term, but the assumption is that Provenge...
Reuters:   Global consumer confidence is improving. Reuters:   GM (GM) filed for Chapter 11 and expects a quick exit. Reuters:   Most US retailers probably had sales drop in May. Reuters:  ...